Ethyl-1- (4-Fluorobenzyl) -2-Methyl -1H- Pyrrole-3-Carboxylate

Ethyl-1-(4-fluorobenzyl)-2-methyl-1H-pyrrole-3-carboxylate (CAS not widely catalogued under a harmonized inventory; laboratory registry entries predominate) enters downstream manufacturing streams almost exclusively as a non-isolated intermediate or a building block subjected to further functionalization. The ester moiety, the C-2 methyl substituent, and the 4-fluorobenzyl N-substituent collectively establish a reactivity profile that diverges sharply from unsubstituted pyrrole-3-carboxylates: the fluorine atom withdraws electron density through the benzylic methylene spacer, moderating N-alkylpyrrole oxidation sensitivity, while the C-2 methyl group sterically shields the C-3 ester from direct nucleophilic attack. The following scenarios document authentic integration points in industrial organic synthesis and materials formulation, emphasizing process parameters, analytical verification methods, and documented failure modes.

Hydrolysis to the Free Carboxylic Acid and Subsequent Amide Coupling in API Intermediate Streams

Saponification of the ethyl ester to yield 1-(4-fluorobenzyl)-2-methyl-1H-pyrrole-3-carboxylic acid represents the highest-volume transformation observed in contract manufacturing organization (CMO) batch records. The steric environment created by the ortho-methyl group slows hydroxide attack relative to unsubstituted pyrrole-3-carboxylates. Aqueous sodium hydroxide (2.5–3.0 M, 3.5–4.0 equivalents) in a 1:1 (v/v) ethanol/water co-solvent system at reflux (80–82°C internal temperature) achieves >97% conversion within 6–8 hours when monitored by TLC (silica gel 60 F₂₅₄, hexane:ethyl acetate 3:1, R_f ester ≈ 0.65, R_f acid ≈ 0.05 baseline streak). Abandoned reaction mixtures left at ambient temperature for >24 hours develop a green-brown discoloration attributable to oxidative oligomerization at the unsubstituted C-4 and C-5 positions of the pyrrole ring; this chromogenic degradation pathway is accelerated by dissolved oxygen and necessitates nitrogen sparging (0.2 L/min per kg reaction mass) during the hydrolysis hold period. The free acid precipitates upon acidification to pH 2.0–2.5 with concentrated HCl at 0–5°C, yielding an off-white crystalline solid with a melting point range of 158–161°C (DSC onset, 10°C/min ramp, N₂ atmosphere).

Conversion of this carboxylic acid to substituted amides proceeds through the intermediate acid chloride, generated with oxalyl chloride (1.1–1.3 eq) in anhydrous dichloromethane containing catalytic DMF (0.5 mol%) at 0–25°C over 2 hours. The exotherm during DMF addition is reproducible but controllable: a 200 L glass-lined reactor equipped with a retreat-curve impeller at 120 rpm typically records a 4–6°C temperature spike. Direct coupling of the acid chloride with primary or secondary amines—most commonly N-methylpiperazine, morpholine, or substituted benzylamines—in the presence of triethylamine (2.5 eq) at 0–10°C affords the corresponding amides in 72–89% isolated yield after silica gel chromatography (gradient elution, 5→40% ethyl acetate in heptane). The C-2 methyl group exerts a measurable influence on amide rotamer populations: ¹H NMR spectra (CDCl₃, 400 MHz) of N-methylpiperazine amide derivatives display split N-CH₂ resonances at δ 3.42–3.78 with a coalescence temperature of approximately 318 K, consistent with a rotational barrier (ΔG‡) of ~64 kJ/mol estimated by line-shape analysis. This barrier exceeds that of the des-methyl analogue by ~6 kJ/mol, a steric effect that influences the conformational preorganization of API candidates incorporating this scaffold. Downstream medicinal chemistry programs targeting kinase inhibition motifs and GPCR allosteric modulators consume these amide intermediates at the 100 g–5 kg scale per campaign, with the fluorobenzyl substituent serving as a metabolically stable lipophilic anchor that occupies hydrophobic pockets in target binding sites.

What Happens When the C-5 Position Undergoes Electrophilic Bromination Under Kinetic Control?

Regioselective functionalization of the pyrrole C-5 position (the position alpha to nitrogen and adjacent to the C-2 methyl group) with N-bromosuccinimide (NBS) proceeds with predictable regiochemistry dictated by the combined directing effects of the N-(4-fluorobenzyl) substituent and the C-2 methyl group. In anhydrous DMF at −10 to −5°C, NBS (1.02–1.05 eq, added portionwise over 45 minutes) delivers C-5 bromination with >20:1 regioselectivity over the C-4 position. The reaction endpoint is determined by HPLC (C18 column, 250 × 4.6 mm, 5 μm particle size, acetonitrile/water 65:35 isocratic, 1.0 mL/min, UV detection at 254 nm): the starting material elutes at t_R ≈ 8.2 min; the C-5 bromide product at t_R ≈ 11.7 min; the C-4 bromide isomer at t_R ≈ 10.4 min. Temperature excursions above +5°C during NBS addition erode regioselectivity to approximately 8:1 and increase dibrominated byproduct (t_R ≈ 14.9 min) from <1% to 4–7 area%.

Ethyl 5-bromo-1-(4-fluorobenzyl)-2-methyl-1H-pyrrole-3-carboxylate serves as a versatile cross-coupling substrate. Suzuki-Miyaura coupling with arylboronic acids bearing electron-donating or mildly electron-withdrawing substituents proceeds efficiently using Pd(PPh₃)₄ (2 mol%) and aqueous Na₂CO₃ (2 M, 3 eq) in 1,4-dioxane at 90°C for 12–18 hours. Electron-deficient boronic acids (e.g., 4-nitrophenylboronic acid) require PdCl₂(dppf)·CH₂Cl₂ (3 mol%) and K₃PO₄ (2 eq) in THF/water (4:1) to overcome sluggish transmetallation; under these conditions, 65–78% isolated yields are typical. The C-5 arylated products exhibit restricted rotation about the C-5–aryl bond when the introduced aryl group carries ortho substituents—¹⁹F NMR spectroscopy (CDCl₃, 376 MHz) of ortho-tolyl adducts reveals diastereotopic fluorobenzyl signals (Δδ ≈ 0.12 ppm) at ambient temperature, with coalescence observed at 340–345 K. This atropisomerism has been exploited in asymmetric catalysis programs where the axial chirality of the biaryl-pyrrole system is used to transfer stereochemical information in enantioselective transformations. Kilogram-scale bromination campaigns (15–25 kg input material) in a 500 L Hastelloy C-276 reactor require jacket temperature control set to −15°C (inlet) to compensate for the 12–18 kJ/mol exotherm measured by reaction calorimetry (Mettler Toledo RC1e, isothermal mode at −5°C). The brominated intermediate is isolated by drowning the reaction mixture into 5 volumes of ice-water, filtering the precipitated solid, and drying under vacuum (40°C, 10 mbar, 12 hours) to a water content of <0.2% (Karl Fischer titration).

The SPhos-based system (entry 3) is preferred for API-destined intermediates where residual palladium specifications (typically <100 ppm per ICH Q3D elemental impurity guidelines for oral drug products) must be met without additional metal scavenging steps. A single treatment with activated carbon (Norit SX Plus, 5 wt% relative to product, 60°C, 2 hours) further reduces palladium to 15–35 ppm, enabling compliance with parenteral drug substance limits.

Vilsmeier-Haack Formylation at C-5 in Competition with C-4 Isomer Formation

Treatment of ethyl 1-(4-fluorobenzyl)-2-methyl-1H-pyrrole-3-carboxylate with the Vilsmeier-Haack reagent (POCl₃/DMF, 1:3 molar ratio, generated in situ at 0°C over 30 minutes) in 1,2-dichloroethane at 60°C for 4 hours introduces a formyl group at the C-5 position with ~85:15 regioselectivity favoring C-5 over C-4. The isomers are separable by careful column chromatography (silica gel, hexane:ethyl acetate 8:1→4:1 step gradient), but on a manufacturing scale this separation imposes cost penalties that have driven investigation into selectivity-enhancing additives. Addition of ZnCl₂ (0.5 eq) to the Vilsmeier-Haack complex shifts the C-5:C-4 ratio to approximately 93:7, presumably through chelation-controlled direction of the electrophilic iminium species to the less hindered alpha position. The formylated ester—ethyl 5-formyl-1-(4-fluorobenzyl)-2-methyl-1H-pyrrole-3-carboxylate—is a pale yellow crystalline solid (mp 112–114°C) that displays a characteristic aldehyde proton singlet at δ 9.72 in ¹H NMR and a carbonyl stretch at 1668 cm⁻¹ (FT-IR, KBr pellet). The aldehyde function undergoes condensation with hydrazines and hydroxylamines under standard conditions, yielding hydrazone and oxime derivatives that have been screened in fragment-based drug discovery campaigns targeting metalloprotease enzymes. Reductive amination of the C-5 aldehyde with primary amines and NaBH(OAc)₃ (1.5 eq) in 1,2-dichloroethane containing 1% acetic acid proceeds to >90% conversion within 6 hours at ambient temperature; the resulting C-5 aminomethyl derivatives exhibit enhanced aqueous solubility (0.5–2.1 mg/mL in phosphate-buffered saline at pH 7.4) relative to the parent formyl compound (<0.05 mg/mL), a property exploited in lead optimization for oral bioavailability.

When the Fluorobenzyl Group Becomes the Reactive Site: Catalytic Hydrogenolysis as a Debenzylation Strategy

The 4-fluorobenzyl N-substituent, while serving as a robust protecting group through multistep synthetic sequences, can be selectively cleaved under hydrogenolytic conditions that leave the pyrrole ring and the C-3 ester intact. This transformation converts a tertiary N-alkylpyrrole into a secondary pyrrole (ethyl 2-methyl-1H-pyrrole-3-carboxylate, a lower molecular weight intermediate with distinct reactivity), enabling late-stage N-diversification in parallel synthesis libraries. Hydrogenation over Pd(OH)₂/C (20 wt%, Pearlman's catalyst, 10 mol% Pd relative to substrate) in ethanol at 50°C under 50 psi H₂ pressure achieves complete debenzylation within 8–12 hours as monitored by the disappearance of the benzylic methylene singlet (δ 5.08) in ¹H NMR aliquots. The 4-fluorotoluene byproduct is removed by distillation (bp 116–117°C) during solvent recovery, leaving the deprotected pyrrole ester in 88–93% yield after aqueous workup and vacuum distillation (bp 98–102°C at 0.5 mmHg).

Competitive hydrogenation of the pyrrole ring itself is a documented side reaction when catalyst loading exceeds 15 mol% or when the hydrogen pressure is increased above 80 psi. Under these forcing conditions, the pyrrolidine derivative—ethyl 2-methylpyrrolidine-3-carboxylate—forms at 2–5% conversion, detectable by the appearance of a broad N-H stretch at 3320–3350 cm⁻¹ in the IR spectrum of the crude product and by the disappearance of aromatic pyrrole C-H signals in the δ 6.15–6.50 region of the ¹H NMR spectrum. Production-scale hydrogenolysis in a 50 L Parr stirred pressure reactor (316L stainless steel, magnetic drive agitator at 600 rpm) processes 3–5 kg batches with a typical cycle time of 16 hours including catalyst filtration over a Celite pad, solvent exchange, and distillation. The deprotected pyrrole ester is an amber liquid at ambient temperature (density 1.089 g/mL at 20°C, refractive index n_D²⁰ = 1.5112) that darkens upon prolonged exposure to air; storage under nitrogen with 50–100 ppm BHT stabilizer is recommended for inventories held longer than 30 days.

In a configuration where the 4-fluorobenzyl group must be retained while the ester functionality undergoes orthogonal transformation, the hydrogenolysis step can be deferred until after the ester has been converted to a Weinreb amide (N,O-dimethylhydroxylamine hydrochloride, isopropylmagnesium chloride, THF, −15°C, 1 hour). The Weinreb amide withstands the hydrogenolysis conditions without reduction of the amide carbonyl, yielding N-methoxy-N,2-dimethyl-1H-pyrrole-3-carboxamide, a substrate amenable to nucleophilic addition of organolithium and Grignard reagents for the construction of ketone libraries. This sequential functionalization strategy—ester to Weinreb amide, hydrogenolytic debenzylation, then N-alkylation with diverse electrophiles—has been reported to produce 120–180 discrete pyrrole-3-carboxamide analogues in a single parallel synthesis run occupying 3–4 working days on a Chemspeed SWING platform with 96-well reactor blocks.

Melt-Processable Nucleating Agent for Isotactic Polypropylene Clarification: A Non-Medicinal Application

A structurally distinct application domain exists in thermoplastic polymer processing, where the planar pyrrole-ester core—when incorporated at loadings of 0.05–0.25 wt% into isotactic polypropylene (iPP) homopolymer (MFR 3–12 g/10 min per ISO 1133-1:2022, 230°C/2.16 kg)—functions as a heterogeneous nucleating agent that raises the crystallization onset temperature (T_c,onset) by 6–11°C relative to non-nucleated iPP (114–116°C baseline). The mechanism is attributed to epitaxial lattice matching between the (010) plane of the α-crystal modification of iPP and the planar aromatic surface presented by the fluorobenzyl-pyrrole assembly. Differential scanning calorimetry cooling traces (10°C/min, nitrogen purge at 50 mL/min) of nucleated iPP exhibit a single sharp crystallization exotherm with a half-width of 3.2–4.1°C, versus 7.8–9.5°C for the non-nucleated control, indicative of a more uniform crystallite size distribution. The consequent reduction in spherulite diameter—from 40–80 μm to 5–15 μm as measured by polarized optical microscopy on 20 μm microtomed sections—translates to a measurable haze reduction in 1 mm injection-molded plaques from 38–45% to 12–18% (ASTM D1003-21, Procedure A, CIE Illuminant C).

Compounding is executed on a co-rotating twin-screw extruder (L/D 40:1, screw diameter 27 mm, barrel zones set to 180/200/215/225/230/230/225°C from feed to die) at 300 rpm screw speed and 8–12 kg/h throughput. The nucleating agent, supplied as a fine powder (D₅₀ <15 μm by laser diffraction, Malvern Mastersizer 3000), is pre-blended with 500 g of iPP pellets and 0.05 wt% calcium stearate (acid scavenger) prior to gravimetric feeding into the main feed throat. Dispersion quality is verified by scanning electron microscopy of cryofractured extrudate surfaces; agglomerates larger than 5 μm indicate inadequate distributive mixing and necessitate adjustment of the kneading block configuration in the mixing zone. A documented incompatibility arises with certain hindered amine light stabilizers (HALS)—specifically those based on 2,2,6,6-tetramethylpiperidine with secondary amine functionality—which engage in acid-base interactions with the pyrrole nitrogen that deactivate the nucleating surface. Tinuvin 770 (bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate) at 0.1 wt% co-addition erodes the T_c,onset elevation by 3–5°C, whereas Tinuvin 622 (a polymeric HALS with tertiary amine structure, butanedioic acid ester with 4-hydroxy-2,2,6,6-tetramethyl-1-piperidineethanol) exhibits no antagonism at equivalent addition levels. This nuanced formulation constraint has been documented in commercial technical service reports from polymer additive suppliers and informs the selection of stabilizer packages for clarified iPP formulations destined for thin-wall injection molding (wall thickness 0.5–1.2 mm) in food packaging and medical device components.

The fluorobenzyl moiety, while chemically inert under polypropylene processing temperatures (220–240°C melt temperature), contributes a measurable plasticizing effect at nucleating agent loadings above 0.3 wt%. Dynamic mechanical analysis (DMA, 1 Hz, 3°C/min, dual-cantilever geometry) registers a depression of the β-relaxation temperature (T_β, associated with the glass transition of the amorphous iPP phase) from 5–8°C to −2 to +2°C, accompanied by a 12–18% reduction in flexural modulus (ISO 178:2019, 2 mm/min crosshead speed, 23°C, 50% RH). This performance cliff-edge dictates that the practical upper loading limit for clarification applications is 0.20–0.25 wt%; excursions beyond this range convert the additive from a nucleating agent into an unwanted processing aid that sacrifices stiffness for marginal additional haze reduction.

Building Block for Fluorescence-Quenched Molecular Probes Dependent on Photoinduced Electron Transfer

Ethyl 1-(4-fluorobenzyl)-2-methyl-1H-pyrrole-3-carboxylate has been elaborated into fluorophore-quencher conjugates in which the electron-rich pyrrole core acts as a photoinduced electron transfer (PET) donor that modulates the emission intensity of appended fluorescent reporters. The synthetic sequence begins with LiAlH₄ reduction of the ester to the primary alcohol—1-(4-fluorobenzyl)-2-methyl-1H-pyrrole-3-methanol—using 1.2 eq LiAlH₄ in anhydrous THF at 0°C→reflux over 3 hours, yielding the alcohol as a colorless viscous oil (85–90% yield after aqueous workup and passage through a short silica plug with ethyl acetate elution). The benzylic alcohol is activated as the methanesulfonate ester (MsCl, 1.1 eq, Et₃N 1.5 eq, CH₂Cl₂, 0°C, 30 minutes) and displaced with a linker-dye conjugate bearing a terminal primary amine or thiol nucleophile. Conjugation to 5(6)-carboxyfluorescein through a hexamethylenediamine spacer (HBTU coupling, DIPEA, DMF, 23°C, 12 hours) generates a probe molecule in which fluorescein emission (λ_ex 492 nm, λ_em 518 nm in 50 mM Tris buffer, pH 8.0) is quenched by 65–80% relative to an equimolar concentration of free 5(6)-carboxyfluorescein, consistent with efficient PET from the pyrrole HOMO (calculated at approximately −5.8 eV by DFT, B3LYP/6-31G* level) to the photoexcited fluorescein singlet state. The quenching efficiency is pH-dependent: protonation of the pyrrole nitrogen (pK_a ≈ −3.0 to −3.5, estimated by UV-Vis titration in sulfuric acid/water mixtures) eliminates the PET donor capability, restoring fluorescence to 85–92% of the free dye intensity. This pH-gated emission behavior has been evaluated in cellular imaging studies where the probe accumulates in acidic endosomal compartments (pH 5.0–5.5) and reports on organelle acidification dynamics through ratiometric fluorescence microscopy.

An alternative probe architecture employs the C-5 brominated derivative as an electrophilic handle for Sonogashira coupling with propargylamine derivatives, installing an alkyne linker that undergoes copper-catalyzed azide-alkyne cycloaddition (CuAAC) with azide-functionalized biomolecules. The resulting triazole-linked conjugates display Förster resonance energy transfer (FRET) rather than PET when the acceptor dye (typically a rhodamine or cyanine derivative) is attached at the triazole terminus; the pyrrole serves as a non-emissive FRET donor with a calculated Förster radius (R₀) of 2.8–3.2 nm for the pyrrole-to-fluorescein donor-acceptor pair. Published data for this specific configuration is limited to proof-of-concept demonstrations in academic settings (10–100 μM probe concentrations in cuvette-based spectroscopy), and translation to diagnostic assay formats has not been reported.